Dong-A Socio Holdings Co., Ltd. (KRX:000640)
South Korea · Delayed Price · Currency is KRW 89,000
+500 (0.56%)
Aug 7, 2026, 3:30 PM KST
Dong-A Socio Holdings Financials Overview
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 1,452,366 | 1,429,767 | 1,333,230 | 1,132,003 | 1,014,861 | 881,944 |
Revenue Growth | 7.05% | 7.24% | 17.78% | 11.54% | 15.07% | 12.59% |
Gross Profit Gross Profit Growth | 458,283 | 453,958 | 405,958 | 372,673 | 292,011 | 279,312 |
Operating Income Operating Income Growth | 96,560 | 97,773 | 82,095 | 76,882 | 37,855 | 61,564 |
Net Income Net Income Growth | 93,701 | 90,945 | 58,022 | 57,990 | 11,153 | 60,271 |
Earnings Per Share EPS Growth | 14102.68 | 13718.29 | 8749.51 | 8744.46 | 1681.59 | 9192.20 |
EPS Growth | 37.44% | 56.79% | 0.06% | 420.01% | -81.71% | -63.51% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Elimination of Internal Transactions Elimination of Internal Transactions Growth | -234,779 | -231,555 | -209,226 | -239,812 | -179,208 | -187,776 |
Holding Company Holding Company Growth | 85,173 | 81,234 | 60,374 | 58,383 | 54,207 | 55,872 |
Over-The-Counter Drugs and Quasi-Drugs Over-The-Counter Drugs and Quasi-Drugs Growth | 744,125 | 726,283 | 678,687 | 631,026 | 543,014 | 437,370 |
Distribution Distribution Growth | 433,529 | 423,830 | 400,426 | 355,913 | 345,326 | 304,853 |
Packaging/bottled Water & Co., Ltd. Packaging/bottled Water & Co., Ltd. Growth | 164,167 | 160,447 | 142,644 | - | - | - |
Biosimilars and Contract Medicines Biosimilars and Contract Medicines Growth | 102,643 | 103,734 | 58,864 | 51,447 | 27,865 | 20,023 |
Other Other Growth | 157,509 | 165,795 | 201,460 | 136,776 | 118,506 | 138,808 |
Total Total Growth | 1,452,366 | 1,429,767 | 1,333,230 | 1,132,003 | 1,014,861 | 881,944 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 193,938 | 152,015 | 127,345 | 160,494 | 105,757 | 158,472 |
Total Debt Total Debt Growth | 664,901 | 662,552 | 739,965 | 691,882 | 552,134 | 537,583 |
Net Cash (Debt) Net Cash Growth | -470,963 | -510,537 | -612,620 | -531,388 | -446,378 | -379,111 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -70883.13 | -77010.62 | -92381.88 | -80132.21 | -67312.90 | -57821.79 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 242,940 | 227,392 | 82,995 | 158,698 | 75,874 | 131,087 |
Capital Expenditures CapEx Growth | -43,724 | -49,294 | -51,434 | -150,114 | -56,530 | -70,063 |
Free Cash Flow Free Cash Flow Growth | 199,216 | 178,097 | 31,561 | 8,584 | 19,344 | 61,025 |
Free Cash Flow Growth | 252.66% | 464.30% | 267.69% | -55.63% | -68.30% | 86.95% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 31.55% | 31.75% | 30.45% | 32.92% | 28.77% | 31.67% |
Operating Margin | 6.65% | 6.84% | 6.16% | 6.79% | 3.73% | 6.98% |
Pretax Margin | 4.25% | 3.78% | 5.73% | 5.81% | 1.74% | 7.50% |
Profit Margin | 6.45% | 6.36% | 4.35% | 5.12% | 1.10% | 6.83% |
FCF Margin | 13.72% | 12.46% | 2.37% | 0.76% | 1.91% | 6.92% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
| Period Ending | Aug '26 Aug 8, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 |
Dividend Per Share Dividend Per Share Growth | 1650.485 | 1650.485 | 1602.413 | 2073.711 |
Dividend Per Share Growth | 3.00% | 3.00% | -22.73% | - |
Dividend Yield | 1.85% | 1.58% | 1.60% | 2.27% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 8, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 6.31 | 7.76 | 11.83 | 10.89 | 56.89 | 11.92 |
Forward PE | 7.11 | 6.19 | 9.97 | 8.66 | 9.95 | 12.53 |
P/FCF Ratio | 2.96 | 3.96 | 21.75 | 73.55 | 32.80 | 11.78 |
PS Ratio | 0.41 | 0.49 | 0.52 | 0.56 | 0.63 | 0.82 |